Key result
Schellong HR increase ≥43 bpm linked to ~13-fold greater beta-blocker efficacy in long COVID POTS.
Why the study?
Long COVID may present with autonomic dysregulation such as postural orthostatic tachycardia syndrome, prompting investigation into its treatment course.
Does standard POTS treatment including bisoprolol and lifestyle modifications improve heart rate, fatigue, and functional status in patients with long COVID complicated by POTS?
Observational (n=32)
No
Does standard POTS treatment including bisoprolol and lifestyle modifications improve heart rate, fatigue, and functional status in patients with long COVID complicated by POTS?
In patients with long COVID complicated by POTS, a multidisciplinary treatment approach including bisoprolol improved heart rate and performance status, with higher baseline orthostatic heart rate increases predicting better beta-blocker response.
Hypothesis-generating for POTS management in long COVID; prospective trials needed before practice change.
Purpose The coronavirus disease sequelae, known as long coronavirus disease may present with various symptoms. Among these symptoms, autonomic dysregulation, especially postural orthostatic tachycardia syndrome, should be evaluated. This study aimed to investigate the treatment course of long coronavirus disease, with postural orthostatic tachycardia syndrome.Methods The medical records of patients who complained of fatigue and met the criteria for postural orthostatic tachycardia syndrome diagnosis were reviewed. Change in heart rate fatigue score, and employment/education status at the initial and last visits were evaluated.Results Thirty-two patients with long coronavirus disease complicated by postural orthostatic tachycardia syndrome were followed up (16 male and 16 female; median age: 28 years). Three patients had acute-phase pneumonia. The follow-up period was 159 days, and the interval between coronavirus disease onset and initial hospital attendance was 97 days. Some patients responded to beta-blocker therapy. Many patients had psychiatric symptoms that required psychiatric intervention and selective serotonin reuptake inhibitor prescription. Difference in heart rate and performance status, and employment/education status improved from the first to the last clinic visit. Postural orthostatic tachycardia syndrome after severe acute respiratory syndrome coronavirus 2 infection could be treated faster than the syndrome occurring in isolation. This was thought to be due to the effects of various treatment interventions and spontaneous improvements after severe acute respiratory syndrome coronavirus 2 infection.Conclusion Postural orthostatic tachycardia syndrome evaluation must be considered when patients with symptoms of coronavirus disease complain of fatigue.
No takes yet. Share an insight, caveat, or question.
Tsuchida et al. (2023) conducted an observational in Long COVID complicated by postural orthostatic tachycardia syndrome (POTS) (n=32). Maximum heart rate change ≥43 bpm at initial Schellong test vs. Maximum heart rate change <43 bpm was evaluated on Efficacy of beta-blocker therapy (patient awareness of treatment effects) (OR 13.333, 95% CI 1.434-123.989, p=0.017). A maximum heart rate change of ≥43 bpm during the initial Schellong test was significantly associated with beta-blocker efficacy in patients with long COVID complicated by POTS (OR 13.333).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: